LETTER AGREEMENT REGARDING UNSECURED NOTEUnsecured Note Agreement • April 29th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Letter Agreement (“Letter “), dated as of April 28, 2024, is made between Sandia Investment Management LP on behalf of Diametric True Alpha Market Neutral Master Fund LP and Diametric True Alpha Enhanced Market Neutral Master Fund LP (“Lender”) and NKGEN BIOTECH, INC. (“Borrower”).
LETTER AGREEMENT REGARDING UNSECURED NOTELetter Agreement Regarding Unsecured Note • April 29th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
This Letter Agreement (“Letter “), dated as of April 28, 2024, is made between Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (collectively, “Lender”) and NKGEN BIOTECH, INC. (“Borrower”).
